Ganciclovir-induced mutations are present in a diverse spectrum of post-transplant malignancies
暂无分享,去创建一个
S. Leung | J. Wong | I. Majewski | H. Siu | C. Flensburg | E. A. Sweet-Cordero | Mengya Xu | Michelle L. Turski | Helen H N Yan | Michael S. Y. Huen | Rakesh Sharma | J. Barbour | R. Bilardi | H. Fang | E. Chew | Zhen Xu | Ho-Wan Ip | C. Cheung | Haocheng Yang | Siu T. Lam | Junshi Li | H. Ip | Helen H. N. Yan
[1] D. Torrents,et al. Detection of early seeding of Richter transformation in chronic lymphocytic leukemia , 2022, Nature Medicine.
[2] M. Stratton,et al. Mutational landscape of normal epithelial cells in Lynch Syndrome patients , 2022, Nature Communications.
[3] S. Nik-Zainal,et al. Substitution mutational signatures in whole-genome–sequenced cancers in the UK population , 2022, Science.
[4] M. Christie,et al. Germline MBD4 deficiency causes a multi-tumor predisposition syndrome , 2022, American journal of human genetics.
[5] R. van Boxtel,et al. Antiviral treatment causes a unique mutational signature in cancers of transplantation recipients , 2021, Cell stem cell.
[6] M. Kasai,et al. Comparison of Transplantation Outcomes after Foscarnet and Ganciclovir Administration as First-Line Anti-Cytomegalovirus Preemptive Therapy. , 2021, Transplantation and cellular therapy.
[7] Katherine R. Smith,et al. A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damage , 2021, Nature Cancer.
[8] H. Clevers,et al. Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles , 2020, Gut.
[9] Ville Mustonen,et al. The repertoire of mutational signatures in human cancer , 2018, Nature.
[10] C. Cole,et al. The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers , 2018, Nature Reviews Cancer.
[11] M. Stratton,et al. The genomic landscape of cutaneous SCC reveals drivers and a novel azathioprine associated mutational signature , 2018, Nature Communications.
[12] Ian J. Majewski,et al. SuperFreq: Integrated mutation detection and clonal tracking in cancer , 2018, bioRxiv.
[13] Adrian Baez-Ortega,et al. sigfit: flexible Bayesian inference of mutational signatures , 2018, bioRxiv.
[14] Christopher T. Saunders,et al. Strelka2: fast and accurate calling of germline and somatic variants , 2018, Nature Methods.
[15] T. Habermann,et al. Post‐Transplantation Lymphoproliferative Disorders in Adults , 2018, The New England journal of medicine.
[16] Doron Lipson,et al. High-Throughput Genomic Profiling of Adult Solid Tumors Reveals Novel Insights into Cancer Pathogenesis. , 2017, Cancer research.
[17] AACR Project GENIE: Powering Precision Medicine through an International Consortium. , 2017, Cancer discovery.
[18] P. Marquet,et al. Liquid chromatography tandem mass spectrometry quantitation of intracellular concentrations of ganciclovir and its phosphorylated forms , 2015, Analytical and Bioanalytical Chemistry.
[19] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[20] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[21] T. Mazzulli,et al. Post renal transplantation Kaposi's sarcoma: a review of its epidemiology, pathogenesis, diagnosis, clinical aspects, and therapy , 2012, Transplant infectious disease : an official journal of the Transplantation Society.
[22] A. Israni,et al. Spectrum of cancer risk among US solid organ transplant recipients. , 2011, JAMA.
[23] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[24] L. Robison,et al. New malignancies after blood or marrow stem-cell transplantation in children and adults: incidence and risk factors. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[26] H. Einsele,et al. Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. , 2002, Blood.
[27] A. Allison,et al. Mycophenolate mofetil and its mechanisms of action. , 2000, Immunopharmacology.
[28] M. Tomicic,et al. Comparison of the genotoxic and apoptosis-inducing properties of ganciclovir and penciclovir in Chinese hamster ovary cells transfected with the thymidine kinase gene of herpes simplex virus-1: Implications for gene therapeutic approaches , 2000, Cancer Gene Therapy.
[29] G. Elion. The biochemistry and mechanism of action of acyclovir. , 1983, The Journal of antimicrobial chemotherapy.